2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Mini-Oral Session

[MO5] Mini-Oral Session 5　Hepatobiliary / Pancreatic Cancer 2（HCC, Pancreatic Cancer）
【E】

Thu. Feb 17, 2022 1:20 PM - 2:10 PM Room 6 (Room D, 1F, Kyoto International Conference Center)

Chair：Hiroshi Imaoka（Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East），Yasushi Kojima（Department of Gastroenterology, National Center For Global Health and Medicine）

[MO5-5] LAMC2 is a novel predictive biomarker for gemcitabine-based therapy in pancreatic ductal adenocarcinoma

○Yasuyuki Okada, Yasuhiro Mitsui, Yasuteru Fujino, Shinji Kitamura, Koichi Okamoto, Hiroshi Miyamoto, Yasushi Sato, Naoki Muguruma, Tetsuji Takayama (Department of Gastroenterology and Oncology, Tokushima University Graduate School)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password